It's Tuesday, Health Tech readers.
Situational awareness: Besieged digital pharmacy Cerebral is laying off roughly 20% of its workforce, per the WSJ.
Programming note: Health Tech Deals will not be publishing tomorrow while we are hosting our BFD Summit in New York, but we look forward to being back in your inboxes on Thursday.
Bucking an industry-wide investment downturn, several digital health companies raised Series E+ rounds in Q3, including We Doctor and Kyruus, per a recent CB Insights report.
Why it matters: Although the market correction is generally pushing investors away from larger and later-stage rounds, some companies are still scoring big — and most of them are outside the U.S., per the data, Erin writes.
Details: Among the biggest late-stage raisers include the company known for debuting China’s first internet-based hospital, a Japanese disease management business, and an Israeli surgical robot maker.
The intrigue: Only two companies on the list — Kyruus and uLab Systems — are headquartered in the U.S. Both offer software intended to streamline patient care.
View archive